NCT01835288 2018-05-21Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaStanford UniversityPhase 2 Withdrawn
NCT00093483 2014-01-13Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid LeukemiaRoswell Park Cancer InstitutePhase 1 Completed61 enrolled
NCT00003395 2013-06-25Arsenic Trioxide in Treating Patients With Advanced Hematologic CancerMemorial Sloan Kettering Cancer CenterPhase 1 Completed
NCT00005795 2012-06-11Arsenic Trioxide in Treating Patients With Acute Myeloid LeukemiaNorthwestern UniversityPhase 2 Completed11 enrolled